By Scott Flaherty ( June 3, 2013, 6:30 PM EDT) -- Shire LLC on Friday urged a California federal court to throw out putative class allegations that the drug company stifled competition for Adderall XR through patent settlements and supply agreements with generic-drug makers, saying its conduct did not delay entry of a generic....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.